McCourt Marion bought REGN
December 5, 2025 · Form 4 insider transaction
McCourt Marion bought 2,476 shares of Regeneron Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,476
Price
$0.00
Total value
N/A
InsiderMcCourt Marion
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateDecember 5, 2025
Filing dateDecember 9, 2025
Shares owned after16,706
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 5, 2027 and 50% on December 5, 2029.